Urogenital pathogens, associated with Trichomonas vaginalis, among pregnant women in Kilifi, Kenya: a nested case-control study

[1]  L. Coorevits,et al.  Corrigendum to 'Macrolide resistance in Mycoplasma genitalium from female sex workers in Belgium' [J Glob Antimicrob Resist 12 (2018) 149-152]. , 2018, Journal of global antimicrobial resistance.

[2]  D. Taylor-Robinson.  Mollicutes in vaginal microbiology: Mycoplasma hominis, Ureaplasma urealyticum, Ureaplasma parvum and Mycoplasma genitalium. , 2017, Research in microbiology.

[3]  L. Coorevits,et al.  Macrolide resistance in Mycoplasma genitalium from female sex workers in Belgium. , 2017, Journal of global antimicrobial resistance.

[4]  L. Petricevic,et al.  Mycoplasma/Ureaplasma infection in pregnancy: to screen or not to screen , 2017, Journal of perinatal medicine.

[5]  Christine L. Sun,et al.  Candidatus Mycoplasma girerdii replicates, diversifies, and co-occurs with Trichomonas vaginalis in the oral cavity of a premature infant , 2017, Scientific Reports.

[6]  M. Vaneechoutte,et al.  High prevalence of curable sexually transmitted infections among pregnant women in a rural county hospital in Kilifi, Kenya , 2017, PloS one.

[7]  P. Rappelli,et al.  Trichomonas vaginalis infection in symbiosis with Trichomonasvirus and Mycoplasma. , 2017, Research in microbiology.

[8]  M. Kemp,et al.  Ureaplasma parvum genotype, combined vaginal colonisation with Candida albicans, and spontaneous preterm birth in an Australian cohort of pregnant women , 2016, BMC Pregnancy and Childbirth.

[9]  S. Delany-Moretlwe,et al.  A Multi-Country Cross-Sectional Study of Vaginal Carriage of Group B Streptococci (GBS) and Escherichia coli in Resource-Poor Settings: Prevalences and Risk Factors , 2016, PloS one.

[10]  Marleen Temmerman,et al.  Global Estimates of the Prevalence and Incidence of Four Curable Sexually Transmitted Infections in 2012 Based on Systematic Review and Global Reporting , 2015, PloS one.

[11]  F. Jacobs,et al.  Clinical evaluation of a multi-parameter customized respiratory TaqMan® array card compared to conventional methods in immunocompromised patients , 2015, Journal of Clinical Virology.

[12]  M. Vaneechoutte,et al.  Validation of High Resolution Melting Analysis (HRM) of the Amplified ITS2 Region for the Detection and Identification of Yeasts from Clinical Samples: Comparison with Culture and MALDI-TOF Based Identification , 2015, PloS one.

[13]  Odelta dos Santos,et al.  High rates of double-stranded RNA viruses and Mycoplasma hominis in Trichomonas vaginalis clinical isolates in South Brazil. , 2015, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.

[14]  Dan J Stein,et al.  Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013 , 2015, The Lancet.

[15]  Jennifer M. Fettweis,et al.  An Emerging Mycoplasma Associated with Trichomoniasis, Vaginal Infection and Disease , 2014, PloS one.

[16]  M. Vaneechoutte,et al.  Strong Correspondence of the Vaginal and Rectal Load of Group B Streptococci in Pregnant Women , 2013 .

[17]  R. Lillis,et al.  Unique vaginal microbiota that includes an unknown Mycoplasma-like organism is associated with Trichomonas vaginalis infection. , 2013, The Journal of infectious diseases.

[18]  N. Schmidt,et al.  Co-occurrence of Trichomonas vaginalis and bacterial vaginosis among HIV-positive women. , 2011, Sexually transmitted diseases.

[19]  A. Buvé,et al.  Molecular typing of the actin gene of Trichomonas vaginalis isolates by PCR-restriction fragment length polymorphism. , 2008, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

[20]  J. Baeten,et al.  Infection with Trichomonas vaginalis increases the risk of HIV-1 acquisition. , 2007, The Journal of infectious diseases.

[21]  Z. Lun,et al.  Symbiosis of Mycoplasma hominis in Trichomonas vaginalis may link metronidazole resistance in vitro , 2006, Parasitology Research.

[22]  A. Azargoon,et al.  Association of bacterial vaginosis, trichomonas vaginalis, and vaginal acidity with outcome of pregnancy. , 2006, Archives of Iranian medicine.

[23]  A. van Belkum,et al.  A clinical study on the association of Trichomonas vaginalis and Mycoplasma hominis infections in women attending a sexually transmitted disease (STD) outpatient clinic. , 2001, FEMS immunology and medical microbiology.

[24]  P. Fiori,et al.  Mycoplasma hominis parasitism of Trichomonas vaginalis , 1998, The Lancet.

[25]  P. Rappelli,et al.  Mycoplasma hominis parasitism of Trichomonas vaginalis , 1998, The Lancet.

[26]  G. Garber,et al.  Clinical and Microbiological Aspects ofTrichomonas vaginalis , 1998, Clinical Microbiology Reviews.